NCT05858294

Brief Summary

The present study is a randomised controlled trial that seeks to investigate the safety, acceptability and efficacy and safety of the Alena CBT programme as a treatment for social anxiety disorder.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
102

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Oct 2022

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 31, 2022

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 4, 2022

Completed
14 days until next milestone

Study Completion

Last participant's last visit for all outcomes

December 18, 2022

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

April 21, 2023

Completed
24 days until next milestone

First Posted

Study publicly available on registry

May 15, 2023

Completed
Last Updated

May 15, 2023

Status Verified

May 1, 2023

Enrollment Period

1 month

First QC Date

April 21, 2023

Last Update Submit

May 4, 2023

Conditions

Keywords

RCTCBT

Outcome Measures

Primary Outcomes (4)

  • Questionnaires assessing negative effects from using the app and adverse health events

    The Intervention group was asked "Have you experienced any negative effects from using the Alena app? This could be a physical or emotional effect that you believe you have experienced as a result of using the app and/or engaging in the app therapy." Both groups were asked: "Have you experienced any new, serious negative health effects in the past week? This includes having to see your GP for a new reason, going to hospital, or being otherwise very unwell in terms of your physical or mental health." If participants responded positively to either question, they were prompted for additional details and to rate the severity of the experience.

    Week 4 (primary endpoint)

  • Questionnaires assessing negative effects from using the app and adverse health events

    The Intervention group was asked "Have you experienced any negative effects from using the Alena app? This could be a physical or emotional effect that you believe you have experienced as a result of using the app and/or engaging in the app therapy." Both groups were asked: "Have you experienced any new, serious negative health effects in the past week? This includes having to see your GP for a new reason, going to hospital, or being otherwise very unwell in terms of your physical or mental health." If participants responded positively to either question, they were prompted for additional details and to rate the severity of the experience.

    Week 6 (2-week follow-up post-intervention)

  • Questionnaire assessing satisfaction, helpfulness and ease of use

    Participants were asked how satisfied they were with the app overall (Likert rating scale from very dissatisfied to very satisfied); how helpful they found the app (Likert ratings from very unhelpful to very helpful); how likely they would be to recommend the app (Likert ratings from very unlikely to very likely); how easy they found using the app (Likert ratings from very difficult to very easy); whether they got to the end of the weekly exercise (yes/no), and what got in the way of completing the exercises, with options provided.

    Week 4 (primary endpoint)

  • Questionnaire assessing satisfaction, helpfulness and ease of use

    Participants were asked how satisfied they were with the app overall (Likert rating scale from very dissatisfied to very satisfied); how helpful they found the app (Likert ratings from very unhelpful to very helpful); how likely they would be to recommend the app (Likert ratings from very unlikely to very likely); how easy they found using the app (Likert ratings from very difficult to very easy); whether they got to the end of the weekly exercise (yes/no), and what got in the way of completing the exercises, with options provided.

    Week 6 (2-week follow-up post-intervention)

Secondary Outcomes (4)

  • Social phobia inventory (SPIN)

    Week 4 (primary endpoint)

  • Social phobia inventory (SPIN)

    Week 6 (2-week follow-up post-intervention)

  • Work and Social Adjustment Scale (WSAS)

    Week 4 (primary endpoint)

  • Work and Social Adjustment Scale (WSAS)

    Week 6 (2-week follow-up post-intervention)

Study Arms (2)

Cognitive Behavioral Therapy program

EXPERIMENTAL

Access to the "Alena" CBT-based therapy programme for 4 weeks. Each of the four therapy modules gradually became available on a weekly basis until all four were available in the final intervention week. Participants were instructed to complete one module per week. Each therapy module consisted of psychoeducational content, guided psychological reflection and perspective-taking exercises, and, where appropriate, skills training exercises such as attention training, public speaking, and exposure experiments to be completed in real life.

Behavioral: Cognitive Behavioral Therapy programme

Waitlist control

NO INTERVENTION

Waitlist control. Participants in this arm were given access to the CBT content at the end of the 4-week trial period.

Interventions

This mobile application comprised CBT-based therapy for social anxiety based on the Clark and Wells model

Cognitive Behavioral Therapy program

Eligibility Criteria

Age18 Years - 35 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • female
  • aged between 18 and 35 years old (inclusive)
  • located in the UK
  • fluent in English
  • comfortable taking part in a study that included deception (due to the nature of the cognitive assessments)
  • had an iPhone and daily access to an internet connection
  • scored over 30 on the Social Phobia Inventory (SPIN; indicating at least moderate social anxiety).

You may not qualify if:

  • currently undergoing any mental health therapy
  • changed the usual mental health medication or dosage within the past eight weeks
  • scored eight or above on the Alcohol Use Disorders Identification Test for consumption (AUDIT-C; indicating higher risk of alcohol dependence)
  • scored two or above on the adapted drug questions (indicating higher risk of drug dependence)
  • had previously participated in scientific studies or user research undertaken by Alena

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Aya Technologies Limited

London, United Kingdom

Location

Related Publications (3)

  • Connor KM, Davidson JR, Churchill LE, Sherwood A, Foa E, Weisler RH. Psychometric properties of the Social Phobia Inventory (SPIN). New self-rating scale. Br J Psychiatry. 2000 Apr;176:379-86. doi: 10.1192/bjp.176.4.379.

    PMID: 10827888BACKGROUND
  • Mundt JC, Marks IM, Shear MK, Greist JH. The Work and Social Adjustment Scale: a simple measure of impairment in functioning. Br J Psychiatry. 2002 May;180:461-4. doi: 10.1192/bjp.180.5.461.

    PMID: 11983645BACKGROUND
  • Garvert MM, McFadyen J, Linke S, McCloud T, Meyer SS, Sobanska S, Sharp PB, Long A, Huys QJM, Ahmadi M. Safety and Efficacy of Modular Digital Psychotherapy for Social Anxiety: Randomized Controlled Trial. J Med Internet Res. 2025 Apr 10;27:e64138. doi: 10.2196/64138.

MeSH Terms

Conditions

Phobia, Social

Condition Hierarchy (Ancestors)

Phobic DisordersAnxiety DisordersMental Disorders

Study Officials

  • Mandana Ahmadi, PhD

    Aya Technologies Limited

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 21, 2023

First Posted

May 15, 2023

Study Start

October 31, 2022

Primary Completion

December 4, 2022

Study Completion

December 18, 2022

Last Updated

May 15, 2023

Record last verified: 2023-05

Data Sharing

IPD Sharing
Will not share

Locations